DeepRhythmAI
Medicalgorithmics S.A. • Cardiovascular • 07/27/2022
Device Purpose
DeepRhythmAI is a cloud-based software that provides healthcare solution integrators with a tool for developing applications to aid qualified professionals in assessing cardiac arrhythmias in adult patients using two-lead ECG data. The system employs a proprietary deep-learning algorithm for the automated measurement and analysis of ECG signals, identifying various cardiac events and arrhythmias to furnish supportive information for clinical review.
Summary
DeepRhythmAI is a cloud-based software system designed for the automated analysis of electrocardiogram (ECG) data to assess cardiac arrhythmias in adult patients. It utilizes a proprietary deep-learning algorithm and a scalable Application Programming Interface (API), enabling integration with other medical products. The system is intended for use by healthcare solution integrators to develop applications that allow qualified healthcare professionals to review and confirm the analytical results provided by DeepRhythmAI for supportive information. The software supports the analysis of two-lead ECG data recorded from various ambulatory ECG devices, including Holter monitors, event recorders, and Mobile Cardiac Telemetry systems, as well as data transferred from other computer-based ECG management systems. DeepRhythmAI's algorithm detects and analyzes cardiac beats, QRS complexes, heart rate, RR intervals, non-paced arrhythmias, non-paced ventricular arrhythmia calls, ventricular ectopic beats, and supraventricular ectopic beats. Interpretation results are offered on an advisory basis only, to be used in conjunction with a physician's knowledge and other diagnostic information, and are not intended as the sole means of diagnosis or for use in life-supporting systems.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What were the specific performance metrics (e.g., sensitivity, specificity, positive predictive value) of the DeepRhythmAI algorithm for each detected arrhythmia type, such as ventricular and supraventricular ectopic beats, when validated against ANSI/AAMI/IEC 60601-2-47 and AAMI/ANSI/EC57 standards?; How does the DeepRhythmAI algorithm's performance in detecting non-paced arrhythmias vary when analyzing data from different compatible ambulatory ECG devices (e.g., Holter, event recorder, Mobile Cardiac Telemetry)?; What are the technical requirements and potential challenges for healthcare solution integrators when integrating DeepRhythmAI via its API into diverse web or mobile applications, particularly concerning data security and system interoperability?; Considering DeepRhythmAI utilizes a deep-learning algorithm, what types of datasets were employed for its training and validation, and what measures ensure its generalizability across diverse adult patient populations with varying comorbidities?; Since DeepRhythmAI relies on third-party software for visualization, what are the recommended minimum features for such external software to ensure effective review and confirmation of the algorithm's annotations by healthcare professionals?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SBOM, ML-BOM, SaaSBOM detected in AI-generated device summary.
• Not detected in AI-generated device summary: HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly